Malaria No More
Generated by GPT-5-miniExpansion Funnel Raw 64 → Dedup 0 → NER 0 → Enqueued 0
| Malaria No More | |
|---|---|
| Name | Malaria No More |
| Formation | 2006 |
| Type | Nonprofit |
| Leader title | CEO |
Malaria No More is an international nonprofit organization focused on ending deaths caused by malaria. Founded in 2006, it operates within a landscape that includes institutions such as the World Health Organization, United Nations, Bill & Melinda Gates Foundation, and national agencies like United States Agency for International Development and Department for International Development (UK). The organization works alongside actors from Clinton Foundation, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Gavi, the Vaccine Alliance, and private sector partners including Pfizer, GlaxoSmithKline, and Johnson & Johnson.
History
Malaria No More was established in 2006 amid global initiatives like the 2005 World Summit and the expansion of the Millennium Development Goals. Early supporters included figures tied to Rockefeller Foundation, Wellcome Trust, and philanthropists similar to Warren Buffett and Michael Bloomberg. Initial campaigns intersected with programs launched by Roll Back Malaria Partnership and research agendas at institutions such as London School of Hygiene & Tropical Medicine, Harvard School of Public Health, and Johns Hopkins Bloomberg School of Public Health. Over time, the group aligned with policy developments debated at summits such as the United Nations General Assembly and efforts coordinated through forums like Clinton Global Initiative and the World Economic Forum.
Mission and Goals
The stated mission emphasizes accelerating progress toward ending preventable deaths from malaria, echoing targets set by Sustainable Development Goals and guidance from World Health Organization Global Malaria Programme. Goals include scaling interventions promoted by Centers for Disease Control and Prevention, expanding access to tools endorsed by United Nations Children's Fund, and supporting commitments similar to those made in Paris Declaration on Aid Effectiveness. Strategic objectives reflect collaborations with research networks such as Malaria Atlas Project and delivery partners like Doctors Without Borders and Save the Children.
Programs and Initiatives
Programs focus on distribution campaigns for tools recommended by World Health Organization, including long-lasting insecticidal nets advocated by President's Malaria Initiative and indoor residual spraying used in operations by African Union. Initiatives have included advocacy models deployed at events like Clinton Global Initiative Annual Meeting and fundraising campaigns coordinated with broadcasters such as BBC and CNN. Technical work often partners with laboratory and field research institutions like Wellcome Centre for Human Genetics, Kenya Medical Research Institute, and Imperial College London to integrate innovations such as rapid diagnostic tests developed by companies like Abbott Laboratories and vaccines under trials by GlaxoSmithKline and Pfizer.
Partnerships and Funding
Funding streams have combined grants from foundations such as the Bill & Melinda Gates Foundation and corporate support from firms like Unilever and Procter & Gamble. Partnerships extend to multilateral organizations including The Global Fund to Fight AIDS, Tuberculosis and Malaria, Gavi, the Vaccine Alliance, and bilateral donors such as United States Agency for International Development and Department for International Development (UK). Collaborations with research funders such as Wellcome Trust and networks like Africa CDC and PATH (organization) underpin operational activities. Campaign alliances have engaged public figures from realms represented by Clinton Foundation, Barack Obama, Gordon Brown, and Kofi Annan.
Impact and Outcomes
Reported outcomes reference contributions to reductions in malaria mortality consistent with global trends documented by World Health Organization and analyses by Institute for Health Metrics and Evaluation. Programs claim measurable increases in distribution of insecticidal nets and uptake of diagnostics in countries comparable to Nigeria, Kenya, Uganda, Democratic Republic of the Congo, and Mozambique. Evaluations often utilize datasets maintained by Malaria Atlas Project, modeling from Imperial College London, and surveillance reported to World Health Organization Global Malaria Programme. Policy influence is reflected in national strategies adopted in ministries analogous to Ministry of Health (Kenya) and Ministry of Health (Nigeria) and commitments at summits such as the United Nations General Assembly.
Criticism and Controversies
Critiques mirror broader debates involving international NGOs like Oxfam, Médecins Sans Frontières, and ActionAid regarding aid effectiveness, dependency, and alignment with national priorities exemplified by critiques during discussions at Paris Declaration on Aid Effectiveness and Accra Agenda for Action. Some analysts from institutions such as London School of Economics and Chatham House have questioned measurement attribution when multiple actors—including The Global Fund to Fight AIDS, Tuberculosis and Malaria and President's Malaria Initiative—operate concurrently. Controversies also touch on relationships with corporate donors similar to Unilever and Pfizer and debates around public–private partnerships discussed at forums like the World Economic Forum.